Healthcare
Crinetics Pharmaceuticals, Inc.
CRNXPrice is delayed.
About Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals is a drug development company working on treatments for rare hormone-related diseases and tumors. The company's main product candidate, Paltusotine, is an oral pill being tested in late-stage trials for acromegaly (a growth hormone disorder) and carcinoid syndrome (a type of cancer). Crinetics is also developing several other experimental drugs to treat conditions caused by hormone imbalances, including Cushing's disease, thyroid disease, and obesity. The company was founded in 2008 and is based in San Diego, California.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore